US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 7.935
  • +0.035+0.44%
Close May 28 16:00 ET
  • 7.850
  • -0.085-1.07%
Post 19:33 ET
185.72MMarket Cap-666P/E (TTM)

Outlook Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
-4.49%-21.1M
Net income from continuing operations
-1,617.52%-114.29M
40.10%-11.18M
10.70%-58.98M
9.44%-12.99M
-17.87%-20.68M
66.23%-6.65M
-29.04%-18.66M
-24.24%-66.05M
-7.02%-14.35M
-43.81%-17.54M
Operating gains losses
5,075,432.12%83.74M
-90.34%50.79K
-11.61%537.74K
-37.62%-5.44K
108.69%18.94K
-105.31%-1.65K
-34.19%525.89K
22.04%608.35K
98.68%-3.96K
-146.89%-217.91K
Depreciation and amortization
156.29%28.2K
161.60%28.2K
-78.41%44.19K
-78.21%11.22K
-78.17%11.19K
-78.47%11K
-78.81%10.78K
-21.91%204.69K
1.57%51.47K
6.41%51.27K
Other non cash items
--1.69M
-27.58%993K
102.00%5.13M
-169.27%-315.61K
400.47%4.07M
--0
170.42%1.37M
643.16%2.54M
79.62%455.64K
227.80%813.56K
Change In working capital
55.84%-1.26M
-164.98%-4.2M
382.19%4.75M
-189.78%-1.99M
156.28%3.14M
-474.19%-2.86M
608.97%6.46M
76.21%-1.68M
-26.30%2.22M
44.01%-5.57M
-Change in prepaid assets
-595.95%-524.12K
-410.12%-2.45M
184.61%2.62M
30.80%1.79M
103.38%113.96K
90.67%-75.31K
376.18%788.51K
-78.78%-3.09M
-73.56%1.37M
39.64%-3.37M
-Change in payables and accrued expense
73.60%-731.16K
-130.84%-1.75M
63.40%2.37M
-543.20%-3.8M
248.51%3.26M
-275.18%-2.77M
370.87%5.68M
126.40%1.45M
139.74%857.98K
51.08%-2.19M
-Change in other current assets
----
----
---208.2K
--24.02K
---232.22K
----
----
--0
--0
----
-Change in other current liabilities
--0
--0
37.01%-27K
--0
63.94%-3.93K
-11.06%-11.64K
-11.27%-11.42K
71.50%-42.85K
-11.26%-11.21K
77.56%-10.9K
Cash from discontinued investing activities
Operating cash flow
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
-4.49%-21.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
6.05%59.59M
-56.93%1.63M
-516.26%-11.3M
Net issuance payments of debt
62.48%-1.08K
-100.02%-3.18K
952.41%19.77M
45.79%-3.08K
99.97%-2.98K
99.06%-2.89K
106.20%19.78M
-136.77%-2.32M
71.17%-5.69K
-60,197.58%-11.6M
Net common stock issuance
16,647.34%56.14M
--0
-51.81%30.02M
48.75%2.43M
1,025.98%3.3M
-112.44%-339.28K
-57.27%24.64M
34.57%62.31M
-56.92%1.63M
-89.29%293K
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
-94.27%205.85K
--0
--0
Net other financing activities
----
----
-37.32%-823.89K
--0
--0
---254.96K
5.18%-568.93K
-7,370.12%-600K
--0
--0
Cash from discontinued financing activities
Financing cash flow
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
6.05%59.59M
-56.93%1.63M
-516.26%-11.3M
Net cash flow
Beginning cash position
-80.21%10.36M
34.46%23.39M
20.17%17.4M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
20.17%17.4M
15.49%14.48M
32.14%26.02M
57.19%58.42M
Current changes in cash
523.25%36.87M
-137.30%-13.04M
105.35%6M
-19.62%-10.32M
69.39%-9.92M
25.71%-8.71M
-37.23%34.94M
50.39%2.92M
-65.39%-8.62M
-85.40%-32.4M
End cash Position
8.25%47.23M
-80.21%10.36M
34.46%23.39M
34.46%23.39M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
20.17%17.4M
20.17%17.4M
32.14%26.02M
Free cash flow
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
-4.49%-21.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M-4.49%-21.1M
Net income from continuing operations -1,617.52%-114.29M40.10%-11.18M10.70%-58.98M9.44%-12.99M-17.87%-20.68M66.23%-6.65M-29.04%-18.66M-24.24%-66.05M-7.02%-14.35M-43.81%-17.54M
Operating gains losses 5,075,432.12%83.74M-90.34%50.79K-11.61%537.74K-37.62%-5.44K108.69%18.94K-105.31%-1.65K-34.19%525.89K22.04%608.35K98.68%-3.96K-146.89%-217.91K
Depreciation and amortization 156.29%28.2K161.60%28.2K-78.41%44.19K-78.21%11.22K-78.17%11.19K-78.47%11K-78.81%10.78K-21.91%204.69K1.57%51.47K6.41%51.27K
Other non cash items --1.69M-27.58%993K102.00%5.13M-169.27%-315.61K400.47%4.07M--0170.42%1.37M643.16%2.54M79.62%455.64K227.80%813.56K
Change In working capital 55.84%-1.26M-164.98%-4.2M382.19%4.75M-189.78%-1.99M156.28%3.14M-474.19%-2.86M608.97%6.46M76.21%-1.68M-26.30%2.22M44.01%-5.57M
-Change in prepaid assets -595.95%-524.12K-410.12%-2.45M184.61%2.62M30.80%1.79M103.38%113.96K90.67%-75.31K376.18%788.51K-78.78%-3.09M-73.56%1.37M39.64%-3.37M
-Change in payables and accrued expense 73.60%-731.16K-130.84%-1.75M63.40%2.37M-543.20%-3.8M248.51%3.26M-275.18%-2.77M370.87%5.68M126.40%1.45M139.74%857.98K51.08%-2.19M
-Change in other current assets -----------208.2K--24.02K---232.22K----------0--0----
-Change in other current liabilities --0--037.01%-27K--063.94%-3.93K-11.06%-11.64K-11.27%-11.42K71.50%-42.85K-11.26%-11.21K77.56%-10.9K
Cash from discontinued investing activities
Operating cash flow -137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M-4.49%-21.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M6.05%59.59M-56.93%1.63M-516.26%-11.3M
Net issuance payments of debt 62.48%-1.08K-100.02%-3.18K952.41%19.77M45.79%-3.08K99.97%-2.98K99.06%-2.89K106.20%19.78M-136.77%-2.32M71.17%-5.69K-60,197.58%-11.6M
Net common stock issuance 16,647.34%56.14M--0-51.81%30.02M48.75%2.43M1,025.98%3.3M-112.44%-339.28K-57.27%24.64M34.57%62.31M-56.92%1.63M-89.29%293K
Proceeds from stock option exercised by employees ----------0--0-------------94.27%205.85K--0--0
Net other financing activities ---------37.32%-823.89K--0--0---254.96K5.18%-568.93K-7,370.12%-600K--0--0
Cash from discontinued financing activities
Financing cash flow 9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M6.05%59.59M-56.93%1.63M-516.26%-11.3M
Net cash flow
Beginning cash position -80.21%10.36M34.46%23.39M20.17%17.4M29.54%33.71M-25.32%43.63M-25.39%52.34M20.17%17.4M15.49%14.48M32.14%26.02M57.19%58.42M
Current changes in cash 523.25%36.87M-137.30%-13.04M105.35%6M-19.62%-10.32M69.39%-9.92M25.71%-8.71M-37.23%34.94M50.39%2.92M-65.39%-8.62M-85.40%-32.4M
End cash Position 8.25%47.23M-80.21%10.36M34.46%23.39M34.46%23.39M29.54%33.71M-25.32%43.63M-25.39%52.34M20.17%17.4M20.17%17.4M32.14%26.02M
Free cash flow -137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M-4.49%-21.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg